U

Ultragenyx Pharmaceutical

Develops and commercializes rare-disease therapies

Key Account Manager

Field SalesPosted on Nov 9
Full-timeEngland, UK

About the Job

Requirements

  • A university degree in Medicine, Biology, Chemistry, Pharmacy, or an equivalent degree.
  • Three to five years of sales experience in secondary care, with a proven record of success in product launches in highly specialized therapeutic areas.
  • Experience in marketing and sales of orphan drugs.
  • Experience engaging key opinion leaders.
  • Experience organizing educational events.
  • Analytical skills.
  • Thorough knowledge of the local industry code of conduct and relevant legislation.
  • Good understanding of the national health care system and decision-making pathways in hospitals and the regional ecosystem.
  • A valid EU type B driver's license is mandatory.
  • Ability to undertake regular, frequent road travel, including overnight stays; up to 80% travel is required.
  • Experience using Microsoft Office software.
  • Fluency in English.

Responsibilities

  • Independently and continuously analyze market potential, treatment paradigms, and referral patterns in the assigned territory.
  • Develop, execute, and present account plans for key accounts in the territory.
  • Analyze the effectiveness of commercial tactics.
  • Establish sustainable, mutually beneficial relationships with opinion leaders and other key stakeholders in the territory, leveraging personal contacts.
  • Optimize patient care by aligning decision-makers involved in treatment decisions, including specialists, nurses, pharmacists, and payers.
  • Develop and execute strategies to identify undiagnosed or misdiagnosed patients.
  • Exchange regularly with peers to share best practices.
  • Monitor changes in the health care system to identify new business opportunities.
  • Support local market access in regions and hospitals to ensure patients have sustainable access to pharmaceutical innovation.

About the Company

Ultragenyx Pharmaceutical

Develops and commercializes rare-disease therapies

Ultragenyx develops and commercializes therapies for rare and ultra-rare genetic diseases. Its products move from clinical development to FDA approval and market, including burosumab for Tumor Induced Osteomalacia and UX007 for Long-chain Fatty Acid Oxidation Disorders. The company differentiates itself with a diversified pipeline and a strong commitment to uninterrupted patient access, serving a niche, high-need market. Its goal is to translate scientific research into effective, accessible treatments and establish leadership in the rare-disease treatment market.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Novato, CA
Founded
2010

Recently Posted Jobs

Explore more opportunities at Ultragenyx Pharmaceutical

See more jobs